Form 8-K - Current report:
SEC Accession No. 0001493152-24-046908
Filing Date
2024-11-20
Accepted
2024-11-19 21:41:45
Documents
15
Period of Report
2024-11-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 34216
2 ex99-1.htm EX-99.1 31815
  Complete submission text file 0001493152-24-046908.txt   243290

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE btcy-20241115.xsd EX-101.SCH 3021
4 XBRL LABEL FILE btcy-20241115_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE btcy-20241115_pre.xml EX-101.PRE 24169
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3355
Mailing Address 203 REDWOOD PARKWAY SUITE 600 REDWOOD CITY CA 94065
Business Address 203 REDWOOD PARKWAY SUITE 600 REDWOOD CITY CA 94065 (650) 832-1626
BIOTRICITY INC. (Filer) CIK: 0001630113 (see all company filings)

EIN.: 472548273 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-40761 | Film No.: 241478035
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)